Skip to main content

Synamatix, GeneWorks Partner on Next-Gen Sequencing, Analysis Services

NEW YORK (GenomeWeb News) – Synamatix, a bioinformatics firm based in Kuala, Lumpur, Malaysia, said today that it is partnering with Australian genomic services shop GeneWorks to provide next-generation sequencing services and bioinformatics support to customers in Asia and Australia.
 
Under the terms of the partnership, GeneWorks will provide sequencing services on the Illumina Genome Analyzer platform, while Synamatix will provide bioinformatics analysis using its SynaWorks platform, a suite of tools targeted at analyzing data from the Illumina and Roche/454 sequencing instruments.
 
The companies said that the first project they are working on is “an initiative covering the de novo sequencing of microbial organisms,” but did not disclose further details.
 
The companies said that they expect their combined services to appeal to small and medium-sized research institutions “by enabling scientists to enhance and accelerate their research without being limited by a lack of bioinformatics resources or capabilities.”

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.